Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$0.53 - $3.25 $244,520 - $1.5 Million
-461,359 Reduced 75.0%
153,786 $268,000
Q4 2022

Feb 14, 2023

BUY
$0.45 - $0.86 $45,000 - $86,000
100,000 Added 19.41%
615,145 $320,000
Q2 2022

Aug 05, 2022

BUY
$0.47 - $0.87 $23,500 - $43,500
50,000 Added 10.75%
515,145 $299,000
Q1 2022

May 12, 2022

BUY
$0.75 - $1.77 $37,500 - $88,500
50,000 Added 12.04%
465,145 $366,000
Q4 2021

Feb 08, 2022

BUY
$1.56 - $2.93 $78,000 - $146,500
50,000 Added 13.69%
415,145 $673,000
Q3 2021

Nov 05, 2021

BUY
$2.91 - $4.83 $223,543 - $371,035
76,819 Added 26.64%
365,145 $1.1 Million
Q2 2021

Aug 09, 2021

BUY
$4.17 - $5.74 $83,400 - $114,800
20,000 Added 7.45%
288,326 $1.35 Million
Q3 2020

Nov 13, 2020

BUY
$4.9 - $7.12 $191,031 - $277,580
38,986 Added 17.0%
268,326 $1.64 Million
Q3 2019

Nov 08, 2019

BUY
$5.58 - $14.47 $498,517 - $1.29 Million
89,340 Added 63.81%
229,340 $2.57 Million
Q2 2019

Aug 09, 2019

BUY
$5.22 - $9.08 $208,800 - $363,200
40,000 Added 40.0%
140,000 $848,000
Q1 2019

May 10, 2019

BUY
$5.35 - $9.82 $133,750 - $245,500
25,000 Added 33.33%
100,000 $787,000
Q4 2018

Feb 05, 2019

BUY
$3.43 - $6.19 $85,750 - $154,750
25,000 Added 50.0%
75,000 $372,000
Q3 2018

Nov 09, 2018

BUY
$4.75 - $14.5 $118,750 - $362,500
25,000 Added 100.0%
50,000 $237,000
Q2 2018

Aug 08, 2018

BUY
$13.3 - $17.45 $332,500 - $436,250
25,000 New
25,000 $340,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Staley Capital Advisers Inc Portfolio

Follow Staley Capital Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.